Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about NanoViricides
Recent news which mentions NanoViricides
Is This Ticker That InvestorObservers Expects To Soar By More Than 350% Next Year On Your Watchlist?
Today 8:50 EST
Tags
Partner Content
Market News
Biotech
From
Benzinga
NanoViricides updates progress on Phase 1a/1b clinical trial of antiviral drug candidate NV-387
November 29, 2023
Tags
NanoViricides
XNYS:NNVC
From
TheNewswire.com - RSS (Media)
Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant
October 02, 2023
Tickers
AZN
GSK
NNVC
PFE
Tags
General
NNVC
Biotech
From
Benzinga
Multi-Billion Dollar Treatment Market For Lung Infection That Causes Over 200,000 Hospitalizations Annually With Elderly, Young At Most Risk Has Game-Changing New Entrant
September 26, 2023
Tickers
AZN
GSK
NNVC
PFE
Tags
Market News
Penny Stocks
PFE
From
Benzinga
First Human Clinical Trials Of A Potentially "Game-Changing Broad Spectrum Antiviral" Are Progressing Successfully – Drug Could Treat COVID, RSV And Many Other Respiratory Viruses
September 18, 2023
Tickers
PFE
Tags
Biotech
Partner Content
General
From
Benzinga
NanoViricides progressing well with new Covid study
August 31, 2023
Tags
NanoViricides
XNYS:NNVC
From
TheNewswire.com - RSS (Media)
SARS-CoV-2 Is Not Done Yet — Could This New Drug In Clinical Trials Be The Safest Option For Treating COVID-19?
July 18, 2023
Tickers
GILD
MRK
NNVC
PFE
Tags
Benzinga
NanoViricides
PFE
From
Benzinga
NanoViricides testing oral gummy and syrup Covid-19 treatment - Proactive Research Analyst
July 13, 2023
Tags
NanoViricides
XNYS:NNVC
From
TheNewswire.com - RSS (Media)
NanoViricides Inc. (NYSE American: NNVC) Begins Long-Awaited Clinical Trials For Its Anti-Viral Nanomedicine NV-CoV-2, Oral, Amid Continuing Need For COVID Treatment
July 05, 2023
Tickers
GILD
MRK
NNVC
PFE
Tags
PFE
Benzinga
NanoViricides
From
Benzinga
NanoViricides take big step forward beginning trials on its antiviral drug NV-CoV-2
June 29, 2023
Tags
NanoViricides
XNYS:NNVC
From
TheNewswire.com - RSS (Media)
This Biotech's Stock Has Been Under Pressure, Could Upcoming Clinical Trials Of Its Nanotechnology-Based COVID Drug Candidate Be The Start Of An Upward March?
April 19, 2023
Tickers
SGEN
SGMO
SRPT
Tags
Market News
SGEN
Penny Stocks
From
Benzinga
NanoViricides using unique technology platform to fight against viruses
April 12, 2023
Tags
NanoViricides
XNYS:NNVC
From
TheNewswire.com - RSS (Media)
COVID Remains A Global Threat – NanoViricides Set To Begin Clinical Trials For Pan-Coronavirus Drug To Help Defeat COVID Once And For All
March 31, 2023
Tickers
AZN
GILD
MRK
MRNA
Tags
NVAX
Partner Content
General
From
Benzinga
A Company With Solutions Against Emerging COVID Variants And Other Viral Infections To Combat Future Pandemic Threats
March 20, 2023
Tickers
GILD
MRK
MRNA
NVAX
Tags
Biotech
Small Cap
MRNA
From
Benzinga
With Nearly 20,000 Americans Still Hospitalized, COVID Remains A Threat – NanoViricides Gets Ready To Begin Clinical Trials For The World To Defeat It, And To Prepare For Battling Against The Next Lik
March 08, 2023
Tickers
NNVC
Tags
Market News
Benzinga
NanoViricides
From
Benzinga
This Company Is Looking For A Monkeypox Drug As City Investigates Deaths
October 27, 2022
Tickers
NNVC
Tags
Penny Stocks
NanoViricides
Benzinga
From
Benzinga
European Patent Office Issues Intent To Grant Longeveron Patent Related To Methods To Monitor Efficacy Of Lomecel-B™ Cell Therapy
August 26, 2022
Tickers
LGVN
Tags
NanoViricides
Benzinga
Market News
From
Benzinga
European Patent Office Issues Intent To Grant Longeveron Patent Related To Methods to Monitor Efficacy of Lomecel-B™ Cell Therapy
August 26, 2022
Tickers
LGVN
Tags
NanoViricides
Benzinga
Market News
From
Benzinga
Omicron BA.4/5 Subvariants Are More Contagious And More Treatment-Resistant, But This Biopharma Reports Working On A Potential Breakthrough
August 03, 2022
Tickers
LLY
PFE
Tags
Partner Content
News
Biotech
From
Benzinga
NanoViricides Patents Its Antiviral Nanotechnology for COVID-19, Continuing Its Development of Potentially Broad-Spectrum Drugs That Are Expected To Be Effective Even Against Emerging Variants
May 25, 2022
Tickers
MRNA
NNVC
PFE
Tags
Market News
NanoViricides
Benzinga
From
Benzinga
NanoViricides Begins Drug Development Against Severe Pediatric Hepatitis; Expects To Be Successful In Short Period If Existing Candidates In Drug Library Prove Effective
May 18, 2022
Tags
General
Benzinga
NanoViricides
From
Benzinga
NanoViricides Reports That It Has Begun Drug Development To Combat Recent Cases Of Severe Pediatric Hepatitis
May 16, 2022
Tags
General
Partner Content
Biotech
From
Benzinga
Does the FDA Rollback Of Regeneron And Eli Lilly COVID Treatment EUAs Signal A Need To Look Beyond Monoclonal Antibodies? NanoViricides, Inc. Looks To Meet This Need With A New Approach
February 28, 2022
Tickers
GSK
LLY
NNVC
REGN
Tags
LLY
Penny Stocks
NanoViricides
From
Benzinga
Booster Shots Might Not Be Enough to Beat Omicron, According to Some Nanotech Experts
January 19, 2022
Tickers
BNTX
NNVC
PFE
Tags
Partner Content
Biotech
BNTX
From
Benzinga
NanoViricides Says Data Shows Its New Antiviral Could Fight all COVID-19 Variants
December 22, 2021
Tickers
MRK
PFE
Tags
NanoViricides
Benzinga
PFE
From
Benzinga
NanoViricides Attempts to Leverage Decades of Combined Pharmaceutical and Biotech Experience To Bring Broad-Spectrum COVID-19 Antiviral to Market
December 20, 2021
Tickers
MRNA
NNVC
PFE
Tags
Partner Content
MRNA
Biotech
From
Benzinga
NanoViricides Says Its Nanomedicine Tech Could Be the Key To Defeating Omicron and Other COVID-19 Variants
December 09, 2021
Tickers
JNJ
MRNA
NNVC
PFE
Tags
General
NNVC
Biotech
From
Benzinga
These Biotech Companies Are Attempting to Use Improved Antibody Technology in the Fight To Eradicate COVID-19
November 29, 2021
Tickers
ABCL
AZN
HGEN
LLY
Tags
HGEN
NNVC
Biotech
From
Benzinga
Are Pfizer, Moderna, J&J Booster Shots a Panacea? This Company Says Its Broad-Spectrum Drugs to Fight COVID-19 Would Help End the Pandemic
November 02, 2021
Tickers
JNJ
MRNA
NNVC
PFE
Tags
NanoViricides
Benzinga
PFE
From
Benzinga
NanoViricides Announces COVID-19 Clinical Drug Candidate NV-CoV-2 was Effective Against SARS-CoV-2, Further Demonstrating Its Broad-Spectrum Pan-Coronavirus Activity
October 11, 2021
Tickers
NNVC
Tags
General
NNVC
Press Releases
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.